Last reviewed · How we verify
Reference(Stillen tab.)
Stillen is a medication used to treat hypothyroidism.
Stillen is a medication used to treat hypothyroidism. Used for Hypothyroidism.
At a glance
| Generic name | Reference(Stillen tab.) |
|---|---|
| Sponsor | Daewon Pharmaceutical Co., Ltd. |
| Drug class | Thyroid hormone replacement |
| Modality | Small molecule |
| Therapeutic area | Endocrinology |
| Phase | Phase 3 |
Mechanism of action
Stillen contains levothyroxine, a synthetic form of the thyroid hormone thyroxine, which helps to replace the hormone when the thyroid gland does not produce enough. This medication works by increasing the levels of thyroxine in the body, which helps to regulate metabolism and other bodily functions.
Approved indications
- Hypothyroidism
Common side effects
- Nausea
- Headache
- Fatigue
Key clinical trials
- To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients (PHASE3)
- A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601 (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reference(Stillen tab.) CI brief — competitive landscape report
- Reference(Stillen tab.) updates RSS · CI watch RSS
- Daewon Pharmaceutical Co., Ltd. portfolio CI